| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9178501 | Nutrition, Metabolism and Cardiovascular Diseases | 2005 | 7 Pages |
Abstract
Acute nateglinide administration improves postprandial glycaemia and fibrinolytic activity in patients with type 2 diabetes. This combined effect, if confirmed by a long-treatment study, might reduce cardiovascular risk in type 2 diabetes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
N. Tentolouris, E. Boutati, N. Karambakalis, D. Perea, A.D. Tselepis, C. Tsoukala, D. Kyriaki, E. Lourida, I. Anastasopoulou, A. Karafoullidou, S.A. Raptis, N. Katsilambros,